Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2022
In fiscal year 2022, Aurobindo Pharma's net debt to EBITDA ratio was negative 0.58, down from fiscal year 2020. The net profit of the pharmaceutical company before taxes was over 26 billion Indian rupees in financial year 2021.